Molecular Tumor Board

Se trata de un curso que nace a raíz de una de las sesiones formativas que realiza cada 15 días el Servicio de Oncología Médica del Hospital Clínic de Barcelona (HCB). En este curso se presentan casos clínicos simulando un MTB de tumores sólidos, con un objetivo principal, mejorar el conocimiento específico del impacto clínico del perfil molecular en tumores sólidos.



Está destinado a médicos oncólogos y a estudiantes y profesionales vinculados a la oncología médica. Cada seminario que conforma el curso lo presenta un profesional de una patología diferente del Servicio de Oncología Médica del HCB.

• Is there any role for presicion medicine in ampullary cancer? by Dra. Tamara Sauri
• Upper GI tumor
• Targeted therapy in upper tract urinary cancer by Dra. Laia Fernández
• What are the odds? Not everything that glitters is gold by Dr. Lucio Ghiglione
• Focused on agnostic biomarker
• Beyond HER2 amplification: do HER2 mutations play a role in Breast Cancer? by Dra. Isabel García
• Breast Cancer
• Unexpected response to IO in a patient with advanced colorectal cancer by Dr. Juan Carlos Laguna
• Colorectal cancer
• Ataxia Teleangectasia Mutations (ATM) and advanced prostate cancer by Dra. Caterina Aversa
• dMMR/MSI-H facor predictivo en CCR localizado by Dr. Reinaldo Moreno
• Colorectal cancer
• Multiples tumors in a young patient ¿genetic or casuality? by Dra. Laura González
• Thyroid cancer
• Tackling KRAS G12C mutation in NSCLC by Dr. Francisco Javier Muñoz
• Lung Cancer
• Presicion Medicine in NSCLC by Dra. Laura Mezquita
• Thoracic tumor
• Molecular characterization of agressive prostate cancer by Dra. Marta Garcia de Herreros
• Understanding the True Impact of Molecular Alterations by Dr. David Pesántez
• Colorectal Cancer
• PARP inhibitors in somatic BRCA-mutant breast cancer: beyond germline pathogenetic variants by Dr. Francesco Schettini
• Breast Cancer
• Personalized Treatment Strategies in Metastatic Colon Cancer by Dra. Mariam Rojas
• Colorectal cancer
• Beyond BRCAs in prostate cancer by Dr. Òscar Reig
• Targeted cholangiocarcinoma: myth or reality by Dr. Iván Victoria
• Precision medicine in clinical trials
  
• Rediscovering the uncharted EGFR uncommon mutations by Dra. Teresa Gorria
• Lung Cancer